Lv3
390 积分 2025-10-18 加入
Distinct clinical outcomes according to molecular subgroups in relapsed endometrial carcinoma: A cohort study
2个月前
已完结
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)
6个月前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
6个月前
已完结
Iparomlimab and Tuvonralimab: First Approval
7个月前
已完结
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
7个月前
已完结
PD-1 and Its Ligands in Tolerance and Immunity
7个月前
已完结
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer
7个月前
已完结
Cancer of the cervix uteri
7个月前
已完结
Pembrolizumab for the treatment of cervical cancer
7个月前
已完结
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
7个月前
已完结
皖公网安备34019202002308
